Codon Deoptimization of Selectable Markers for Recombinant Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for recombinant protein production in eukaryotic cells face challenges in achieving high yields, as existing techniques do not effectively enhance the expression of heterologous proteins, particularly in terms of transcription, translation, protein folding, and secretion.

Innovation Solution

The method involves culturing host cells with a vector containing a heterologous polynucleotide sequence and a selectable marker polynucleotide sequence that has been modified to reduce translation efficiency, such as through codon deoptimization, to increase selection pressure and enhance the expression of the heterologous protein.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the translation efficiency of the selectable marker is reduced through sequence modification, then selection pressure increases and heterologous protein expression improves, but the growth rate and viability of host cells deteriorate

Engineering Contradiction:
Improveheterologous protein expressionVSAvoidhost cell viability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

Instead of optimizing the selectable marker for high translation efficiency (conventional approach), the invention deliberately reduces translation efficiency through sequence modifications such as codon deoptimization. This inverted approach creates selection pressure that forces host cells to rely on the heterologous protein expression system, thereby improving heterologous protein expression while maintaining host cell viability through careful balancing of the modification程度

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The invention changes the translation efficiency parameter of the selectable marker by modifying nucleotide sequences (e.g., replacing preferred codons with non-preferred codons, altering mRNA secondary structure). These parameter changes create a controlled reduction in selectable marker translation that increases selection pressure without completely abolishing marker function, thus resolving the contradiction between improved heterologous expression and maintained host cell viability

Inventive Principle:
Principle #35Parameter changes

2Productivity

If sequence modifications are introduced to reduce translation efficiency of the selectable marker, then heterologous protein expression increases, but the complexity of vector construction and method implementation increases

Engineering Contradiction:
Improveheterologous protein expressionVSAvoidvector construction complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention modifies the selectable marker sequence by changing nucleotide parameters (codon usage, GC content, mRNA secondary structure) while maintaining the same amino acid sequence. These parameter changes can be implemented through standardized computational design tools and synthetic biology techniques, making the increased complexity manageable and reproducible

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The sequence modifications applied to the selectable marker serve multiple functions simultaneously: they reduce translation efficiency to increase selection pressure, maintain the same protein function for selection, and can be applied to different selectable markers and host cell systems. This multi-functionality reduces the relative complexity by creating a universal approach that can be adapted across different experimental systems

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS10066231B2Methods for improving recombinant protein expression
Publication Date: 2018.09.04 CMC ICOS BIOLOGICS INC
  • US10066231B2 patent drawing
  • US10066231B2 patent drawing
  • US10066231B2 patent drawing

AI summary

Materials and methods are provided which allowed for increased expression of a transfected gene of interest in a recombinant host cell.